Legislation Encourages Thailand's Smokers to Switch to Safer Nicotine Alternatives

Regulations by 2FIRSTS.ai
Nov.21.2023
Legislation Encourages Thailand's Smokers to Switch to Safer Nicotine Alternatives
The head of Thailand's ECST organization has urged the government to pass legislation promoting the use of safer nicotine alternatives.

According to a media report on November 20th, Asa Saligupta, the head of Thailand's ENDS Smoke and Vape Organization (ECST), has urged the Thai government to legislate in order to encourage smokers to switch to less harmful nicotine alternatives.

 

Asa Saligupta believes that the current restrictions on alternative smoking products in Thailand are driving these products underground, resulting in unregulated markets, endangering government tax revenue, and compelling consumers to continue smoking.

 

Thailand banned e-cigarettes and other electronic nicotine products in 2014, leading to the arrests of local e-cigarette users and foreign tourists. Sali Gupta stated that this measure prevented smokers from switching to less harmful nicotine alternatives.

 

Saligupta believes that Thailand should follow in the footsteps of the Philippines, which recently passed an e-cigarette law that recognizes the role of Tobacco Harm Reduction (THR) in the anti-smoking movement. THR involves using less harmful alternatives that can mitigate the health effects of combustible tobacco.

 

The Philippines has become the first country in Southeast Asia to pass e-cigarette legislation. This law regulates the sale and use of e-cigarettes, heated tobacco, and other smokeless products exclusively to adult consumers.

 

The Republic Act No. 11900, also known as the Vaporized Nicotine and Non-Nicotine Products Regulation Act, became law in 2022 in Thailand. This e-cigarette legislation regulates the importation, sale, packaging, distribution, use, and promotion of vaporized nicotine and non-nicotine products, as well as other emerging tobacco products such as e-cigarettes and heated tobacco products.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai
SKE Partners with 7-Eleven Korea, Placing Its Products in Over 5,700 Stores
SKE Partners with 7-Eleven Korea, Placing Its Products in Over 5,700 Stores
According to an SKE release published on PR Newswire, the company is expanding its presence in the Korean market through convenience store and specialty retail channels. SKE has partnered with 7-Eleven Korea, placing its products in more than 5,700 stores nationwide, and is also working with OG9’s offline retail and B2B distribution network. On the product side, SKE is focusing on promoting the Crystal Bar TB1000 and Cloud Zero in Korea.
Nov.19 by 2FIRSTS.ai
Following Japan debut, IQOS ILUMA i “Seletti Edition” limited series launches in South Korea.
Following Japan debut, IQOS ILUMA i “Seletti Edition” limited series launches in South Korea.
Philip Morris International (PMI) Korea announced a collaboration with Italian design brand Seletti to launch the IQOS ILUMA i limited “Seletti Edition.” Pre-sales begin on the 29th at IQOS.com for IQOS Club Gold and Platinum members, with sales from the 30th via the website and nine IQOS-owned stores nationwide. PMI previously said the series would debut in Japan first before rolling out to 13 global travel-retail markets.
Oct.29 by 2FIRSTS.ai
Denver to Hold Referendum on Flavored Tobacco Sales Ban; If Approved, Enforcement Begins in 2026
Denver to Hold Referendum on Flavored Tobacco Sales Ban; If Approved, Enforcement Begins in 2026
A referendum to be held on November 4 will determine whether Denver retains its ban on the sale of flavored tobacco/nicotine products. Campaign finance records show that, as of the end of August, the side seeking to repeal the ban had raised $410,000, significantly more than the pro-ban side (about $245,000). The ban took effect in March 2025, but the city had planned to begin enforcement on January 2026; if the referendum overturns the ban, enforcement will not proceed.
Sep.25 by 2FIRSTS.ai
British American Tobacco’s VELO Launches Limited McLaren F1 Edition: US Price Only 60% of EU/UK
British American Tobacco’s VELO Launches Limited McLaren F1 Edition: US Price Only 60% of EU/UK
BAT’s VELO has released a McLaren F1 co-branded, track-themed limited-edition pack in McLaren’s orange-black livery. Pricing is about $4.60 per can in the U.S. versus ~$7.40 in the EU/UK. The collaboration extends BAT’s partnership with McLaren dating back to 2019.
Oct.11 by 2FIRSTS.ai
UK Peer Seeks to Weaken “Generational Smoking Ban” – Report Reveals Discussions with BAT Executive Relative
UK Peer Seeks to Weaken “Generational Smoking Ban” – Report Reveals Discussions with BAT Executive Relative
Lord Strathcarron, a member of the UK House of Lords, has admitted to discussing the government’s Tobacco and Vapes Bill with a relative who holds a senior role at British American Tobacco (BAT). He is advocating amendments to scrap the bill’s core “generational smoking ban” provision, raising questions of potential conflict of interest.
Oct.27